I'm LongbridgeAI, I can summarize articles.Intuitive Surgical (ISRG) fell 1.58% this week to close at $366.70, lagging the S&P 500, which edged up 0.09%, by roughly 1.67 percentage points. The week traced a fade from strength: Monday (31 Aug) ended at $376.86, Tuesday slipped to $369.25, Wednesday hit a weekly high of $382.41 before settling at $371.88, and Thursday and Friday both declined, leaving the stock at $366.70 on Friday (4 Sep), its lowest close of the week. Intraweek range was 5.
The Week
Intuitive Surgical (ISRG) fell 1.58% this week to close at $366.70, lagging the S&P 500, which edged up 0.09%, by roughly 1.67 percentage points. The week traced a fade from strength: Monday (31 Aug) ended at $376.86, Tuesday slipped to $369.25, Wednesday hit a weekly high of $382.41 before settling at $371.88, and Thursday and Friday both declined, leaving the stock at $366.70 on Friday (4 Sep), its lowest close of the week. Intraweek range was 5.2%, with daily volume about 24% below the median, pointing to a quiet drift rather than a heavy sell-off.
Key Events
There were no company-specific product, earnings or regulatory announcements this week. The conversation centred on the stock’s relative performance within medical devices. Monday’s reports showed Intuitive outperforming rival health-care equipment names, while Tuesday’s session turned softer and left the stock underperforming peers. A separate piece noted that Wall Street was not shaken by what has been one of the stretchiest patches for Intuitive in years, with analysts more focused on the high-end surgical equipment cycle than on short-term price swings.
Analyst Ratings
Among 33 institutions covering ISRG, 17 rate it buy, 7 rate it overweight, 8 rate it hold and 1 rates it sell. The consensus rating is buy, with a consensus target of $478.00933, which sits about 30.35% above the current price. Targets range from $324.00 to $685.00, a wide spread that indicates disagreement on how far the recovery can extend. Within the medical devices industry, ISRG ranks first out of 142 names by ratings.
The Week Ahead
Next week’s macro calendar includes the NFIB small business optimism index on Tuesday (8 Sep), followed by jobless claims, final-demand PPI, existing home sales, wholesale sales and EIA natural gas inventories on Thursday (10 Sep). No company-specific earnings or product dates appear in the provided calendar, so attention may stay on relative trading patterns in robotic surgery and on how changes in Treasury yields feed into growth-stock valuations.
In Short
ISRG gave back some of its recent gains in a low-volume week, moving against the broader market. The ratings picture remains uneven rather than one-sided: 24 brokers give buy or overweight ratings, and the consensus target is about 30% above spot, yet the target range is unusually wide. The latest session’s money flows show medium and small-lot net selling, while large-lot flow points the other way. The main things to watch are whether volatility narrows and how Treasury yield moves influence valuations for growth names like ISRG.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.